Drug
Igiv3i Grifols
Igiv3i Grifols: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| IGIV3I Grifols NCT00699140 | Phase 3 | Immune (Idiopathic) Thrombocytopenic Purpura |
Latest
No recent events.
Follow Igiv3i Grifols on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.